• Company
    • Overview
    • Disease Focus
    • Corporate Management
    • Board of Directors
    • Corporate and social responsibility
  • Technology
    • Small Molecule Therapeutics
    • The Endocannabinoid System
  • Pipeline
    • Overview & Timeline
    • URB937
    • URB597
    • Partnerships
  • News
  • Investors
  • Contact

Site Map

Authors

  • exxeladmin
  • ian@audiencemarketing.com

Pages

  • Company
    • Board of Directors
    • Corporate and social responsibility
    • Corporate Management
    • Disease Focus
    • Overview
    • Scientific Advisory Board
  • Contact
  • Home
  • Investors
  • News
  • Pipeline
    • Overview & Timeline
    • Partnerships
    • URB597
    • URB937
  • Privacy Policy
  • Technology
    • Small Molecule Therapeutics
    • The Endocannabinoid System

News

  • Media/Articles

    • NEW YORK TIMES: At 71, She’s Never Felt Pain or Anxiety. Now Scientists Know Why.
    • University of Malta scientists speak of ‘safe way to block seizures with endocannabinoids’
    • Harnessing brain’s internal reserves might help treat epilepsy
    • Daniele Piomelli and Bob Solomon: Why we need pot research
  • News

    • Exxel’s CSO Daniele Piomelli receives Entrepreneurial Leader of the Year award from UC Irvine (UCI) Beall Applied Innovation
  • Home
  • Company
  • Technology
  • Pipeline
  • News
  • Investors
  • Contact

© 2023 Exxcel Pharma

  • Privacy Policy
  • Site Map